The biospecimens we have collected in recent years have inspired more than 10 R&D projects for a wide range of disease areas such as oncology, autoimmune diseases, infectious diseases and neurology. We are determined to pave the way for scientific research and medical advances by providing these valuable biospecimens.
Our biospecimens procurement process begins with the collection of disease-specific samples for the determined research objectives. Examples containing genetic profiles used in oncology and cancer research; immunological parameters for autoimmune diseases; samples containing viral or bacterial challenges for infectious diseases; and in the field of neurology, samples containing neurotransmitters or neuronal components are evaluated in this process.
The collected biospectrums are carefully processed, stored and analyzed in our laboratories. In this process, full compliance with international quality standards and ethical rules is ensured, thus ensuring the reliability and accuracy of the data obtained.
Biospecimens used in R&D projects are of critical importance in understanding disease mechanisms and developing new treatment strategies. For example, biospecimens used in cancer research enable the analysis of the genetic structures of cancer cells and contribute to the development of personalized treatment approaches.
We continue to invest in biospecimens supply and research processes as part of scientific progress in the field of health. We believe that each biopsy is a step towards improving patients’ quality of life. In our future projects, we will continue to contribute to scientific discoveries by expanding the use of these biospecimens and performing in-depth analyzes in more disease areas.